Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

NCX-2216

Known as: NCX2216 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Vaccination with Abeta(1-42) and treatment with NCX-2216, a novel nitric oxide releasing flurbiprofen derivative, have each been… 
2004
2004
Brain inflammation is an underlying factor in the pathogenesis of Alzheimer's disease (AD) and epidemiological studies indicate… 
  • figure 5
  • table I
2004
2004
NCX-2216 [3-[4-(2-fluoro-α-methyl-[1,1′-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester] is an NO… 
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Highly Cited
2002
Highly Cited
2002
3-4-(2-Fluoro-α-methyl-[1,1′-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester (NCX-2216), a nitric… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2002
2002
BACKGROUND Defective endothelium-dependent relaxation is observed in experimental and human diabetes mellitus. The nature of this…